| 词条 | ReNeuron |
| 释义 |
|name = ReNeuron |type = Public company |traded_as = {{lse|RENE}} |foundation = 1997 |location = Surrey, England, UK |key_people = chairman = Trevor Jones |industry = Stem cell research & development |homepage = reneuron.com }} ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases. ReNeuron is currently testing the effects of neural stem cells on spinal cords for neuroregeneration.[1] They are also testing the use of fetal stem cells on stroke patients.[2] See also
References1. ^{{cite news|last=Cookson |first=Clive |title=Regenerative medicine: Possibilities multiply for nerve cell regrowth |url=http://www.ft.com/cms/s/0/966d45f4-5649-11df-b835-00144feab49a.html|accessdate=23 May 2010|date=4 May 2010}} 2. ^{{cite news|title=EU agency prepares to assess first stem cell drug|url=https://www.reuters.com/article/idUSTRE64B4NA20100512|accessdate=23 May 2010|newspaper=Reuters|date=12 May 2010}} External links
3 : Biotechnology companies of the United Kingdom|Biotechnology companies established in 1997|1997 establishments in the United Kingdom |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。